- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about SNY
Recent news which mentions SNY
This chart gives one reason European stocks may continue to outperform U.S. equities
February 17, 2023
From MarketWatch
BioRestorative (NASDAQ: BRTX) Ramps Up Production In Anticipation Of Positive Phase 2 Results
February 03, 2023
From Benzinga
Nasdaq Futures Deflate As Apple Leads Tech Disappointments: Traders Look To Jobs Data For Mitigating Impact
February 03, 2023
From Benzinga
Sanofi Expects Moderate 2023 Profit Growth On Dupixent Demand, But Dampened By Aubagio Generics Competition
February 03, 2023
Tickers
SNY
From Benzinga
Alphabet, Apple And 3 Stocks To Watch Heading Into Friday
February 03, 2023
From Benzinga
Fear & Greed Index Remains In 'Greed' Zone As Nasdaq Record Sharp Gains For Fourth Straight Week
February 03, 2023
From Benzinga
Tickers
SNY
From MarketWatch
From Benzinga
Sanofi Layoffs 2023: What to Know About the Latest SNY Job Cuts
January 31, 2023
Tickers
SNY
From InvestorPlace
Sanofi Might Pull Down Shutters For Two Vaccine Plants In India
January 30, 2023
Tickers
SNY
From Benzinga
Europe Approves Regeneron-Sanofi's Dupixent For Expanded Use In Eosinophilic Esophagitis
January 30, 2023
From Benzinga
Can Market Sustain Upward Momentum In Tech-Heavy Earnings Week? Apple, Amazon, AMD, Alphabet, Ford Among Key Quarterly Reports To Watch
January 29, 2023
From Benzinga
Could This Vaccine Become Sanofi's Latest Blockbuster?
January 29, 2023
From Motley Fool
7 Blue-Chip Stocks to Buy as a New Bull Market Emerges
January 26, 2023
From InvestorPlace
Wall Street Thinks These 2 Blazing Healthcare Stocks Could Have 21% to 30% Upside in 2023
January 23, 2023
From Motley Fool
Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot
January 13, 2023
From Benzinga
Drug companies plan to raise prices on vital medicines to fund R&D, but they already spend more on shareholder returns
January 13, 2023
From MarketWatch
From Benzinga
What This Drug News Could Mean for Sanofi Shareholders
January 08, 2023
From Motley Fool
5 Top Pharma Stocks of 2022 to Buy for the Long Haul
January 06, 2023
From InvestorPlace
From Benzinga
Could This Drug News Give a Lift to Eli Lilly Stock?
January 01, 2023
From Motley Fool
3 Medical Dividend Stocks That Hit the Sweet Spot
December 26, 2022
From Motley Fool
After Five Years Of Collaboration, Sanofi & Innate Pharma Expand Oncology Pact With Additional Programs
December 19, 2022
From Benzinga
2 Best Biotech Stocks to Buy Right Now
December 16, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.